Clinical trial
Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia
NCT07468383 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Basic and Clinical Study of Cardiac Ganglion Catheter Ablation for the Treatment of Significant Bradycardia
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2025
- Completion date
- July 31, 2028
- Enrollment
- 188 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autonomic nervous system diseases, symptomatic bradycardia